H.R. 2004
Tyler’s Law
Sponsor: Ted Lieu
65 cosponsors
- Angie Craig
- Mariannette Miller-Meeks
- Cory Mills
- Lori Trahan
- Randy K. Weber, Sr.
- Paul Tonko
- Gus M. Bilirakis
- Janice D. Schakowsky
- Robin L. Kelly
- Chris Pappas
- Debbie Wasserman Schultz
- Dan Crenshaw
- David G. Valadao
- Debbie Dingell
- Dina Titus
- Don Bacon
- Eleanor Holmes Norton
- Juan Ciscomani
- Marc A. Veasey
- Michael Lawler
- Nanette Diaz Barragán
- Raja Krishnamoorthi
- Raúl M. Grijalva
- Robert E. Latta
- Sarah McBride
- Scott H. Peters
- Sharice Davids
- Sheila Cherfilus-McCormick
- Sydney Kamlager-Dove
- Troy Balderson
- Neal P. Dunn
- Raul Ruiz
- Darren Soto
- Jay Obernolte
- Nikki Budzinski
- Joe Neguse
- Joe Wilson
- Carol D. Miller
- Joyce Beatty
- John H. Rutherford
- Russell Fry
- Daniel Meuser
- Gabe Evans
- Jennifer L. McClellan
- Kim Schrier
- Brian K. Fitzpatrick
- Rudy Yakym III
- Robert P. Bresnahan, Jr.
- Randy Fine
- Ryan Mackenzie
- Thomas R. Suozzi
- Young Kim
- Alexandria Ocasio-Cortez
- Monica De La Cruz
- Tim Moore
- Madeleine Dean
- Greg Landsman
- Josh Gottheimer
- Zachary Nunn
- Gabe Vasquez
- Mark Alford
- August Pfluger
- Robert Menendez
- Chrissy Houlahan
- Timothy M. Kennedy
Official summary
Written by the Congressional Research Service.
Tyler’s Law
This bill requires the Department of Health and Human Services (HHS) to complete, within one year after the bill’s enactment, a study on how frequently Medicare-participating hospital emergency departments test for fentanyl in patients experiencing an overdose, the costs associated with such testing, and how such testing may impact patients.
Within six months after the study’s completion and based on its results, HHS must issue guidance regarding (1) whether hospital emergency departments should implement fentanyl testing as a routine procedure for patients experiencing an overdose, (2) how to ensure clinicians know which substances they are testing for in routine drug tests, and (3) how fentanyl testing may affect the future risk of overdose and other health outcomes.
Text of the bill
(a) Study. Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services shall complete a study to determine—
(1) how frequently hospital emergency departments test for fentanyl (in addition to testing for other substances such as amphetamines, phencyclidine, cocaine, opiates, and marijuana) when a patient is experiencing an overdose;
(2) the costs associated with such testing for fentanyl;
(3) the potential benefits and risks for patients receiving such testing for fentanyl; and
(4) how fentanyl testing in hospital emergency departments may impact the experience of the patient, including—
(A) protections for the confidentiality and privacy of the patient’s personal health information; and
(B) the patient-physician relationship.
(b) Guidance. Not later than 6 months after completion of the study under subsection (a), based on the results of such study, the Secretary of Health and Human Services shall issue guidance on the following:
(1) Whether hospital emergency departments should implement fentanyl testing as a routine procedure for patients experiencing an overdose.
(2) How hospitals can ensure that clinicians in their hospital emergency departments are aware of which substances are being tested for in their routinely-administered drug tests, regardless of whether those tests screen for fentanyl.
(3) How the administration of fentanyl testing in hospital emergency departments may affect the future risk of overdose and general health outcomes.
(c) Definition. In this section, the term hospital emergency department means a hospital emergency department as such term is used in section 1867(a) of the Social Security Act (42 U.S.C. 1395dd(a)).